1. Cytogenetic and dosimetric effects of 131I in patients with differentiated thyroid carcinoma: comparison between stimulation with rhTSH and thyroid hormone withdrawal treatments
   Márcia Augusta da Silva et al, 2016, Radiation and Environmental Biophysics CrossRef
2. Thyroid Remnant Radioiodine Ablation with Recombinant Human Thyrotropin
   Richard J. Robbins et al, 2016, Thyroid Cancer CrossRef
3. Retrospective Biological Dosimetry at Low and High Doses of Radiation and Radioiodine Impact on Individual Susceptibility to Ionizing Radiation
   Antonina Cebulska-Wasilewska et al, 2017, Genome Integrity CrossRef
4. Cytotoxic and genotoxic effects of 131I and 60Co in follicular thyroid cancer cell (WRO) with and without recombinant human thyroid‐stimulating hormone treatment
   Flávia Gomes Silva Valgôde et al, 2017, Environmental and Molecular Mutagenesis CrossRef
5. Clinical Significance of Diffuse Intrathoracic Uptake on Post-Therapy I-131 Scans in Thyroid Cancer Patients
   Hyun Su Choi et al, 2014, Nuclear Medicine and Molecular Imaging CrossRef
6. A Quantitative Evaluation of Hepatic Uptake on I-131 Whole-Body Scintigraphy for Postablative Therapy of Thyroid Carcinoma
   Michihiro Nakayama et al, 2015, Medicine CrossRef
7. Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSH
   Robin Bacher et al, 2019, Journal of Nuclear Medicine CrossRef
8. A Randomized Controlled Trial for the Effectiveness of Aromatherapy in Decreasing Salivary Gland Damage following Radioactive Iodine Therapy for Differentiated Thyroid Cancer
   Michihiro Nakayama et al, 2016, BioMed Research International CrossRef
9. Initial Radioiodine Ablation
   Rebecca L. Weiss et al, 2017, Management of Thyroid Nodules and Differentiated Thyroid Cancer CrossRef